![](/img/cover-not-exists.png)
A phase II study of leucovorin (LV)-modulated continuous infusion (CI) fluorouracil (DU) + CPT-11 alternating with LV-modulated CI FU + Oxaliplatin (L-OHP) in advanced colorectal cancer (CCR): high activity and low toxicity
Aschele, A., Lonardi, S., Sartor, L., Perin, A., Koussis, B., Nicoletto, O., Monfardini, S.Volume:
37
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(01)81633-6
Date:
April, 2001
File:
PDF, 194 KB
english, 2001